DEUTSCHE BANK AG\ - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 20 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$0100
-50.0%
0.00%
Q2 2017$0
-100.0%
200
-50.0%
0.00%
Q1 2017$1,0000.0%400
-38.1%
0.00%
Q3 2015$1,0006460.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 16,802,500$5,209,0000.31%
WEDBUSH SECURITIES INC 20,000$6,0000.00%
US BANCORP \DE\ 40,650$13,0000.00%
WELLS FARGO & COMPANY/MN 100$00.00%
NORTHERN TRUST CORP 14,553$5,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 44,270$14,0000.00%
PANAGORA ASSET MANAGEMENT INC 107,430$33,0000.00%
MORGAN STANLEY 5,000$2,0000.00%
Invesco Ltd. 10,323$3,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders